APA

Sibon D., Ertault M., Al Nawakil C., de Bazelaire C., Franchi P., Brière J., de Kerviler E., Beranger N., Thieblemont C. & Brice P. (20120608). Combined ifosfamide, etoposide and oxalipatin chemotherapy, a low-toxicity regimen for first-relapsed or refractory Hodgkin lymphoma after ABVD/EBVP: a prospective monocentre study on 34 patients. : British journal of haematology.

Chicago

Sibon David, Ertault Marjane, Al Nawakil Chadi, de Bazelaire Cédric, Franchi Patricia, Brière Josette, de Kerviler Eric, Beranger Nathalie, Thieblemont Catherine and Brice Pauline. 20120608. Combined ifosfamide, etoposide and oxalipatin chemotherapy, a low-toxicity regimen for first-relapsed or refractory Hodgkin lymphoma after ABVD/EBVP: a prospective monocentre study on 34 patients. : British journal of haematology.

Harvard

Sibon D., Ertault M., Al Nawakil C., de Bazelaire C., Franchi P., Brière J., de Kerviler E., Beranger N., Thieblemont C. and Brice P. (20120608). Combined ifosfamide, etoposide and oxalipatin chemotherapy, a low-toxicity regimen for first-relapsed or refractory Hodgkin lymphoma after ABVD/EBVP: a prospective monocentre study on 34 patients. : British journal of haematology.

MLA

Sibon David, Ertault Marjane, Al Nawakil Chadi, de Bazelaire Cédric, Franchi Patricia, Brière Josette, de Kerviler Eric, Beranger Nathalie, Thieblemont Catherine and Brice Pauline. Combined ifosfamide, etoposide and oxalipatin chemotherapy, a low-toxicity regimen for first-relapsed or refractory Hodgkin lymphoma after ABVD/EBVP: a prospective monocentre study on 34 patients. : British journal of haematology. 20120608.